Cargando…

Patients with overlap autoimmune disease differ from those with ‘pure’ disease

OBJECTIVE: To determine frequency, demographic and treatment characteristics of patients with an overlapping second autoimmune illness (2nd AI). METHODS: We analysed two cohorts containing 897 patients with ‘pure’ systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), Sjögren's syndrome...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lockshin, Michael D, Levine, Alana B, Erkan, Doruk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Epidemiology and Outcomes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4422903/ https://www.ncbi.nlm.nih.gov/pubmed/25973214 http://dx.doi.org/10.1136/lupus-2015-000084

Ejemplares similares

Outcome of patients with autoimmune diseases in the intensive care unit: a mixed cluster analysis
por: Bernal-Macías, Santiago, et al.
Publicado: (2015)

High disease activity status suggests more severe disease and damage accrual in systemic lupus erythematosus
por: Koelmeyer, Rachel, et al.
Publicado: (2020)

Disease duration, age at diagnosis and organ damage are important factors for cardiovascular disease in SLE
por: Nived, Ola, et al.
Publicado: (2020)

Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus
por: Sivakumaran, Jagan, et al.
Publicado: (2021)

Risk factors of disease flares in a Chinese lupus cohort with low-grade disease activity
por: Sun, Fangfang, et al.
Publicado: (2022)

Gender differences in SLE: report from a cohort of 417 Caucasian patients
por: Trentin, Francesca, et al.
Publicado: (2023)

Predictors of persistent disease activity and long quiescence in systemic lupus erythematosus: results from the Hopkins Lupus Cohort
por: Giannakou, Ioanna, et al.
Publicado: (2018)

Transition to severe phenotype in systemic lupus erythematosus initially presenting with non-severe disease: implications for the management of early disease
por: Nikolopoulos, Dionysis S, et al.
Publicado: (2020)

Remission and low disease activity in systemic lupus erythematosus: an achievable goal even with fewer steroids? Real-life data from a monocentric cohort
por: Tani, Chiara, et al.
Publicado: (2018)

Utility of the AVISE Connective Tissue Disease test in predicting lupus diagnosis and progression
por: Liang, Emily, et al.
Publicado: (2020)

Disease activity patterns over time in patients with SLE: analysis of the Hopkins Lupus Cohort
por: Györi, Noémi, et al.
Publicado: (2017)

Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures
por: Thanou, Aikaterini, et al.
Publicado: (2019)

Flare rates and factors determining flare occurrence in patients with systemic lupus erythematosus who achieved low disease activity or remission: results from a prospective cohort study
por: Hao, Yanjie, et al.
Publicado: (2022)

Evaluating disease control following belimumab treatment in patients with SLE enrolled in the US OBSErve study
por: Hunnicutt, Jacob N, et al.
Publicado: (2022)

Attribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus Registry
por: Plantinga, Laura C, et al.
Publicado: (2016)

Progression of subclinical and clinical cardiovascular disease in a UK SLE cohort: the role of classic and SLE-related factors
por: Haque, Sahena, et al.
Publicado: (2018)

Quick Systemic Lupus Activity Questionnaire (Q-SLAQ): a simplified version of SLAQ for patient-reported disease activity
por: Svenungsson, Elisabet, et al.
Publicado: (2021)

Achieving remission or low disease activity is associated with better outcomes in patients with systemic lupus erythematosus: a systematic literature review
por: Ugarte-Gil, Manuel Francisco, et al.
Publicado: (2021)

Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus
por: Yoshida, Tsuneyasu, et al.
Publicado: (2022)

Association of one-point glucocorticoid-free status with chronic damage and disease duration in systemic lupus erythematosus: a cross-sectional study
por: Sada, Ken-ei, et al.
Publicado: (2022)

Prevalence of systemic lupus erythematosus-related symptoms assessed by using the Connective Tissue Disease Screening Questionnaire in a large population-based cohort
por: Lambers, Wietske, et al.
Publicado: (2021)

Marital status and age of systemic lupus erythematous diagnosis: the potential for differences related to sex and gender
por: Brailovski, Eugene, et al.
Publicado: (2019)

Frequency, severity and costs of flares increase with disease severity in newly diagnosed systemic lupus erythematosus: a real-world cohort study, United States, 2004–2015
por: Hammond, Edward R, et al.
Publicado: (2021)

Disease and economic burden increase with systemic lupus erythematosus severity 1 year before and after diagnosis: a real-world cohort study, United States, 2004–2015
por: Jiang, Miao, et al.
Publicado: (2021)

Real-world burden of systemic lupus erythematosus in the USA: a comparative cohort study from the Medical Expenditure Panel Survey (MEPS) 2016–2018
por: Grabich, Shannon, et al.
Publicado: (2022)

Within-trial economic analysis of flare data from the BLISS-SC trial of subcutaneous belimumab in systemic lupus erythematosus
por: Lokhandwala, Tasneem, et al.
Publicado: (2021)

Ventricular conduction is a marker for arrhythmic risk in overlap sodium channel disease
por: Wijeyeratne, Y, et al.
Publicado: (2023)

Hospitalisation for systemic lupus erythematosus associates with an increased risk of mortality in Australian patients from 1980 to 2014: a longitudinal, population-level, data linkage, cohort study
por: Raymond, Warren David, et al.
Publicado: (2021)

2021 DORIS definition of remission in SLE: final recommendations from an international task force
por: van Vollenhoven, Ronald F, et al.
Publicado: (2021)

Evaluation of the LFA-REAL clinician-reported outcome (ClinRO) and patient-reported outcome (PRO): data from the Peruvian Almenara Lupus Cohort
por: Ugarte-Gil, Manuel Francisco, et al.
Publicado: (2020)

Strong viral associations with SLE among Filipinos
por: Vista, Evan S, et al.
Publicado: (2017)

Tacrolimus in non-Asian patients with SLE: a real-life experience from three European centres
por: Tani, Chiara, et al.
Publicado: (2018)

Infection-related hospitalisation in young adults with systemic lupus erythematosus: data from the National Inpatient Sample
por: Dhital, Rashmi, et al.
Publicado: (2023)

Systemic Lupus Erythematosus Risk Probability Index: ready for routine use? Results from a Chinese cohort
por: Zhang, Lin, et al.
Publicado: (2023)

Overcoming barriers to recruitment and retention of African–American women with SLE in behavioural interventions: lessons learnt from the WELL study
por: Drenkard, Cristina, et al.
Publicado: (2020)

Evaluation of structured data from electronic health records to identify clinical classification criteria attributes for systemic lupus erythematosus
por: Walunas, Theresa L, et al.
Publicado: (2021)

Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study
por: Tani, Chiara, et al.
Publicado: (2022)

Severe flares are associated with a poorer health-related quality of life (HRQoL) in patients with SLE: data from the Almenara Lupus Cohort
por: Ugarte-Gil, Manuel Francisco, et al.
Publicado: (2022)

COVID-19 prognosis in systemic lupus erythematosus compared with rheumatoid arthritis and spondyloarthritis: results from the CONTROL-19 Study by the Italian Society for Rheumatology
por: Scirocco, Chiara, et al.
Publicado: (2023)

A better self-efficacy is predictive of better health-related quality of life (HRQoL) in patients with systemic lupus erythematosus: data from the Almenara Lupus Cohort
por: Ugarte-Gil, Manuel Francisco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o5b6kl4plv2tdvmrqe5ufk4aoe